Abraxis BioScience
id:
abraxis-bioscience-253-15392806
title:
Abraxis BioScience
text:
Abraxis BioScience was a global biopharmaceutical, and nano-medicine company that developed treatments for critically ill patients. It had over 2000 employees worldwide in 2007. Abraxis's portfolio included the world's first protein-based nanoparticle chemotherapeutic compound, called nab Technology. From this the company developed Abraxane, a treatment for metastatic breast cancer. In 2010, Abraxis BioScience was acquired by Celgene Corporation.
brand slug:
wiki
category slug:
encyclopedia
description:
Former biopharmaceutical and nano-medicine company
original url:
https://en.wikipedia.org/wiki/Abraxis_BioScience
date created:
date modified:
2023-10-22T22:35:46Z
main entity:
{"identifier":"Q4669505","url":"https://www.wikidata.org/entity/Q4669505"}
image:
fields total:
13
integrity:
14